Review Article
Volume 13 Issue 7 - 2021
A Review Article on the Benefit of Melatonin in Ebola Virus Disease Treatment: A Summary of Available Evidence
Diriba Dereje1*, Urge Gerema2, Bekalu Getachew2 and Tesema Etefa2
1Department of Biomedical Sciences (Physiology), Institute of Health, Jimma University, Ethiopia
2Department of Biomedical Sciences (Anatomy), Institute of Health, Jimma University, Ethiopia
*Corresponding Author: Diriba Dereje, Department of Biomedical Sciences (Physiology), Institute of Health, Jimma University, Ethiopia.
Received: December 15, 2020; Published: June 23, 2021




Abstract

Ebola virus disease (EVD) is a viral infectious having high mortality rate. But, there is no yet available proven and recommended treatment. A severe EVD is characterized by insobriety, severe hemorrhages, disseminated intravascular coagulation and multiple organ failure with the development of severe shock. Melatonin application may act on and prevent each of those pathological alterations caused by the EVD. Melatonin possesses pro- and anti-inflammatory properties, limit coagulation problems, can prevent the oxidative stress and inflammatory injury that occurs in the infected endothelial cells, decreases the symptoms, and increases the survival rate after Ebola virus infection. Further clinical trials are mandatory and recommended to explore melatonin side effects, benefits, food and drug interactions, and route of administrations in Ebola virus disease management and prevention of complications.

Keywords: Ebola Virus Disease; Melatonin; A Review

References

  1. Hardeland R., et al. “Melatonin”. The International Journal of Biochemistry and Cell Biology3 (2006): 313-316.
  2. Arendt J and Skene DJ. “Melatonin as a chronobiotic”. Sleep Medicine Reviews1 (2005): 25-39.
  3. Reiter RJ. “Melatonin: clinical relevance”. Best Practice and Research Clinical Endocrinology and Metabolism2 (2003): 273-285.
  4. Feldmann H., et al. “Ebola virus: from discovery to vaccine”. Nature Reviews Immunology8 (2003): 677-685.
  5. Fitzpatrick G., et al. “The Contribution of Ebola Viral Load at Admission and Other Patient Characteristics to Mortality in a Médecins Sans Frontières Ebola Case Management Centre, Kailahun, Sierra Leone, June-October 2014”. The Journal of Infectious Diseases 11 (2015): 1752-1758.
  6. Ebola virus disease (2020).
  7. WHO | Ebola virus disease - Democratic Republic of the Congo (2020).
  8. Organization WH. Ebola Virus Disease Democratic Republic of Congo: External situation report 90. (2020).
  9. Rohan H and McKay G. “The Ebola outbreak in the Democratic Republic of the Congo: why there is no ‘silver bullet”. Nature Immunology6 (2020): 591-594.
  10. Feldmann H and Geisbert TW. “Ebola haemorrhagic fever”. The Lancet9768 (2011): 849-862.
  11. Sanchez A., et al. “Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels”. Journal of Virology19 (2004): 10370-10377.
  12. Zapata JC., et al. “The role of platelets in the pathogenesis of viral hemorrhagic fevers”. PLOS Neglected Tropical Diseases6 (2014).
  13. Kv Z., et al. “[Treatment of Ebola Virus Disease]”. Voenno-Meditsinskii Zhurnal (2015).
  14. Feldmann H and Geisbert TW. “Ebola haemorrhagic fever”. The Lancet9768 (2011): 849-862.
  15. Masters A., et al. “Melatonin, the Hormone of Darkness: From Sleep Promotion to Ebola Treatment”. Brain Disorders and Therapy1 (2014).
  16. Rivera A and Messaoudi I. “Pathophysiology of Ebola Virus Infection: Current Challenges and Future Hopes”. ACS Infectious Diseases5 (2015): 186-197.
  17. Tan D-X., et al. “Ebola virus disease: potential use of melatonin as a treatment”. Journal of Pineal Research4 (2014): 381-384.
  18. Mauriz JL., et al. “A review of the molecular aspects of melatonin’s anti-inflammatory actions: recent insights and new perspectives”. Journal of Pineal Research1 (2013): 1-14.
  19. Tan D-X., et al. “One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?” Journal of Pineal Research1 (2007): 28-42.
  20. Alamili M., et al. “Melatonin suppresses markers of inflammation and oxidative damage in a human daytime endotoxemia model”. Journal of Critical Care1 (2014): 184-e189.
  21. Song J., et al. “The beneficial effect of melatonin in brain endothelial cells against oxygen-glucose deprivation followed by reperfusion-induced injury”. Oxidative Medicine and Cellular Longevity (2014).
  22. Reiter RJ., et al. “Treatment of ebola and other infectious diseases: melatonin “goes viral”. Melatonin Research1 (2020): 43-57.
  23. Geisbert TW., et al. “Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys”. The Lancet9400 (2003): 1953-1958.
  24. Bertuglia S., et al. “Melatonin prevents ischemia reperfusion injury in hamster cheek pouch microcirculation”. Cardiovasc Research6 (1996): 947-952.
  25. Reiter RJ., et al. “Melatonin as an antioxidant: under promises but over delivers”. Journal of Pineal Research3 (2016): 253-278.
  26. Te W and A von SAA. “Clinical Presentation and Management of Severe Ebola Virus Disease”. Annals of the American Thoracic Society (2014).
Citation: Diriba Dereje., et al. “A Review Article on the Benefit of Melatonin in Ebola Virus Disease Treatment: A Summary of Available Evidence”. EC Neurology 13.7 (2021): 43-46.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


November Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 08, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk